References

• 1986Differences Between the Mechanism of Action of MDMA, MBDB, and the Classic Hallucinogens. Identification of a New Therapeutic Class: Entactogens563 cited
• 1987Biochemical and histological evidence that methylenedioxymethylamphetamine (MDMA) is toxic to neurons in the rat brain.453 cited
• 1986Subjective Reports of the Effects of MDMA in a Clinical Setting413 cited
• 1985Hallucinogenic Amphetamine Selectively Destroys Brain Serotonin Nerve Terminals367 cited
• 1988MDMA-induced neurotoxicity: Parameters of degeneration and recovery of brain serotonin neurons312 cited
• 1988(+/-)3,4-Methylenedioxymethamphetamine selectively damages central serotonergic neurons in nonhuman primates300 cited
• 1988Toxic effects of MDMA on central serotonergic neurons in the primate: importance of route and frequency of drug administration245 cited
• 1990Neurochemistry and Neurotoxicity of 3,4‐Methylenedioxymethamphetamine (MDMA, “Ecstasy”)183 cited
• 1992Chronic 3,4-Methylenedioxymethamphetamine (MDMA) Use: Effects on Mood and Neuropsychological Function?168 cited
• 19893,4-Methylenedioxymethamphetamine ("ecstasy") selectively destroys brain serotonin terminals in rhesus monkeys.162 cited
• 1988Drug discrimination studies with MDMA and amphetamine142 cited
• 1992Phenomenology and Sequelae of 3,4-Methylenedioxymethamphetamine Use128 cited
• 1988Stimulant and hallucinogenic behavioral profiles of 3,4-methylenedioxymethamphetamine and N-ethyl-3,4-methylenedioxyamphetamine in rats.